Chemkart India IPO open date is July 7, 2025 and the IPO will close on July 9, 2025.
The company reported revenue of ₹205.46 crores and profit of ₹24.26 crores in 2025.
Chemkart India Limited was incorporated on March 6, 2020, as Chemkart India Private Limited and later converted into a public limited company on October 4, 2024. The company operates from Mumbai and offers a wide range of health, nutritional, and sports supplements including amino acids, vitamins, herbal extracts, and proteins. It operates a B2B model and caters to manufacturers of final consumer supplement products
Chemkart India IPO Details
| IPO Open Date: | July 7, 2025 |
| IPO Close Date: | July 9, 2025 |
| Face Value: | ₹10 Per Equity Share |
| IPO Price Band: | ₹236 to ₹248 Per Share |
| Issue Size: | Approx ₹80.08 Crores |
| Fresh Issue: | Approx ₹64.48 Crores |
| Offer for Sale: | Approx 6,29,200 Equity Shares |
| Issue Type: | Book Build Issue |
| IPO Listing: | BSE SME |
| Retail Quota: | Not more than 35% |
| QIB Quota: | Not more than 50% |
| NII Quota: | Not more than 15% |
Chemkart India IPO Market Lot
The Chemkart India IPO minimum market lot is 600 shares with ₹1,48,800 application amount.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 600 | ₹1,48,800 |
| Retail Maximum | 1 | 600 | ₹1,48,800 |
| S-HNI Minimum | 2 | 1,200 | ₹2,97,600 |
Chemkart India IPO Dates
The Chemkart India IPO date is July 7 and the close date is July 9. The Chemkart India IPO allotment will be finalized on July 10 and the IPO listing on July 14.
| IPO Open Date: | July 7, 2025 |
| IPO Close Date: | July 9, 2025 |
| Basis of Allotment: | July 10, 2025 |
| Refunds: | July 11, 2025 |
| Credit to Demat Account: | July 11, 2025 |
| IPO Listing Date: | July 14, 2025 |
Chemkart India IPO Company Financial Report
Amount ₹ in Crores
| Period Ended | Revenue | Expense | Profit After Tax | Assets |
| 2022 | ₹87.43 | ₹80.11 | ₹5.48 | ₹24.54 |
| 2023 | ₹131.69 | ₹121.17 | ₹7.66 | ₹37.48 |
| 2024 | ₹132.83 | ₹112.87 | ₹14.52 | ₹53.51 |
| 2025 | ₹205.46 | ₹172.86 | ₹24.26 | ₹86.12 |
Chemkart India IPO Valuation – FY2025
Check Chemkart India IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | 0.59 |
| ROCE: | 0.49 |
| EBITDA Margin: | 16.12% |
| PAT Margin: | 0.12 |
| Debt to equity ratio: | 0.32 |
| Earning Per Share (EPS): | ₹25.54 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 45.52% |
| Net Asset Value (NAV): | ₹56.10 |
Chemkart India Business Overview
The company imports, trades, blends, and manufactures amino acids, vitamins, herbal extracts, proteins, and nutritional supplements, with operations across India through both offline and online channels.
- Core Activities: Importing, trading, blending, and manufacturing of health and nutritional supplements.
- Product Categories: Amino Acids, Health Supplements, Herbal Extracts, Nucleotides, Proteins, Sports Nutrition, and Vitamins.
- Facilities: Owns a warehouse at Bhiwandi, Thane, with in-built blending and grinding machinery for customized product processing.
- Clientele: Entirely B2B; products are used in sports, health, and food supplement manufacturing.
- Geographic Reach: Pan-India via offline and online platforms like IndiaMart, Facebook, Instagram, YouTube.
Industry & Market Overview
Chemkart operates in the growing Indian nutraceutical and health supplement industry, driven by rising fitness awareness and preventive healthcare. The market is fragmented, with both large and small players.
- Industry: Nutraceuticals and Health Supplements; part of the broader chemical and manufacturing industry.
- Trends: Growth in fitness, wellness, preventive healthcare, and dietary supplements.
- Competition: Highly fragmented; competition from both organized and unorganized players. Larger players have deeper reach and financial muscle, but Chemkart competes on variety, quality, and pricing.
- Global Trade Outlook: Global goods trade expected to exceed US$ 33 trillion in 2024, driven by services and resilience in emerging economies.
Objects of the Issue
The IPO proceeds will fund a new manufacturing facility (via subsidiary), meet working capital needs, and support general corporate purposes. An OFS of 6.3 lakh shares is also included.
- Fresh Issue:
- To invest in a subsidiary (Easy Raw Materials Pvt. Ltd.) for building a manufacturing and warehouse facility in JNPA SEZ, Navi Mumbai.
- Funding working capital requirements.
- General corporate purposes.
- Offer for Sale (OFS):
- 6,30,000 equity shares by promoters Ankit Shailesh Mehta and Parul Shailesh Mehta
Peer Comparison & Valuation
- No direct peer financials disclosed in DRHP. However, valuation metrics like P/E, P/B, and EV/EBITDA will be critical to assess once price band is announced.
- Sudden rise in margins in FY24 might indicate aggressive valuation is expected.
- Likely valuation benchmark: Nutraceutical and health supplement SMEs listed on NSE/BSE SME platforms.
Chemkart India Promoters & Management
Promoted by Ankit Mehta, Parul Mehta, and Shailesh Mehta, who hold 100% pre-IPO stake. No legal or regulatory issues found with promoters.
- Mr. Ankit Shailesh Mehta
- Ms. Parul Shailesh Mehta
- Mr. Shailesh Vinodrai Mehta
Chemkart India IPO Registrar
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/IPO_Status.html
IPO Lead Managers aka Merchant Bankers
- Smart Horizon Capital Advisors Private Limited
Company Address
Chemkart India Limited
Office No. 403/404,
4th Floor, K.L. Accolade, 6th Road,
TPS III, Santacruz (East), Mumbai – 400055
Mumbai, Maharashtra
Phone: +91 9136383828
Email: investors@chemkart.com
Website: https://chemkart.com/
Chemkart India IPO FAQs
What does Chemkart India Limited do?
It trades and manufactures health, nutrition, and sports supplements for B2B clients.
When Chemkart India IPO will open for subscription?
The IPO is to open on July 7, 2025 for QIB, NII, and Retail Investors. The IPO will close on July 9, 2025.
What is Chemkart India IPO Investors Portion?
The investors’ portion for QIB is 50%, NII is 15%, and Retail is 35%.
What is Chemkart India IPO Issue Size?
Chemkart India IPO issue size is ₹80.08 crores.
What is Chemkart India IPO Price Band?
Chemkart India IPO Price Band is ₹236 to ₹248.
What is Chemkart India IPO Lot Size?
The minimum bid is 600 Shares with ₹1,48,800 amount.
What is the Chemkart India IPO Allotment Date?
Chemkart India IPO allotment date is July 10, 2025.
What is the Chemkart India IPO Listing Date?
Chemkart India IPO listing date is July 14, 2025. The IPO is to list on BSE.
Chemkart India IPO Cash Flow Analysis
Positive operating cash flows align with net profits, showing good liquidity. No mismatch found between profit and cash, and investing cash flow supports future growth.
Chemkart India IPO Risk Factors
Risks include reliance on a few major clients, fluctuating raw material costs, intense competition, and regulatory compliance in health-related products.
Chemkart India Peer Comparison & Valuation View
Though no direct peer data in DRHP, rising margins suggest ambitious pricing. Final P/E, P/B, EV/EBITDA will be key to judge IPO fairness once price is announced.
Chemkart India Related Party Transactions
Includes salary advances and routine transactions with promoters under company policy. No red flags or conflict-prone related party dealings noted.